Home » Topics » BioWorld Science

BioWorld Science
RSS

miRagen launches phase II study of MRG-201

July 11, 2018

Initiation of phase II clinical trial of BPN-14770 in fragile X syndrome

July 11, 2018

New abzymes presented for diagnosing multiple sclerosis

July 11, 2018

Renal anemia treatment: new oral HIF prolyl hydroxylase inhibitor promotes EPO production in rodents

July 11, 2018

APC11 has prognostic significance in colorectal cancer

July 11, 2018

Aeromics initiates phase I study of AER-271 in healthy volunteers

July 11, 2018

New rat model of diabetic cardiopathy described

July 11, 2018

Researchers find novel mutation in CLCC1 gene tied to retinitis pigmentosa

July 11, 2018

Combinations offer new antibiotic possibilities

July 11, 2018

Fixing nuclear transport helps cells cope with premature, normal aging

July 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...